Dark

Check out our API

EMMLF
OKYO PHARMA LTD
stock OTC

Inactive

Aug 2, 2022

0.0300USD-38.017%(-0.0184)6,637

Pre-market

0.00USD-100.000%(-0.05)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 27, 2022

02:00AM EST OKYO Pharma Limited- PDMR Dealing GlobeNewswire Inc

Jan 26, 2022

02:00AM EST OKYO Pharma Limited (LSE: OKYO) a biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain today announces its interim results for the six months ended 30 September 2021. GlobeNewswire Inc

Dec 14, 2021

02:00AM EST OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 GlobeNewswire Inc

Dec 13, 2021

02:00AM EST OKYO Pharma Limited ("OKYO" or the "Company") Announces GlobeNewswire Inc

Dec 6, 2021

02:00AM EST OKYO Pharma Limited("OKYO" or the GlobeNewswire Inc

Dec 1, 2021

02:00AM EST OKYO Pharma Limited ("OKYO" or the "Company") today announces that Bernard Denoyer has been appointed as a non-executive director of the Company with immediate effect. GlobeNewswire Inc

Sep 27, 2021

07:17AM EDT OKYO (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that at the Annual General Meeting, which was held at 10:00 a.m. today, all resolutions were duly passed. GlobeNewswire Inc

Sep 9, 2021

02:00AM EDT OKYO Pharma Limited (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that it will hold its annual general meeting ("AGM") on Monday 27 September 2021 at 10:00 a.m. GlobeNewswire Inc

Aug 2, 2021

06:57AM EDT OKYO Pharma Limited (the Company) is pleased to announce its final audited results for the year ended 31 March 2021. GlobeNewswire Inc

Jun 29, 2021

08:14AM EDT ("OKYO" or the "Company") -OKYO Pharma Retains Ora Inc GlobeNewswire Inc

Apr 28, 2021

02:00AM EDT ("OKYO" or the "Company") -OKYO Pharma Announces GlobeNewswire Inc

Mar 29, 2021

02:00AM EDT OKYO (LSE: OKYO; OTCQB: EMMLF), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, announces that it has appointed Dr Rajkumar Patil as Chief Scientific Officer. GlobeNewswire Inc

Mar 1, 2021

02:00AM EST OKYO Pharma Limited ("OKYO" or the "Company") today announces that it has issued 250,000 ordinary shares of no par value ("Ordinary Shares"), credited as fully paid, at a price of 4.5p per share on the exercise of 250,000 options. GlobeNewswire Inc

Feb 23, 2021

02:00AM EST OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated GlobeNewswire Inc

Jan 19, 2021

02:00AM EST OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces GlobeNewswire Inc

Share